TheProfitWatch

VRCA - Verrica Pharmaceuticals Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.09 0.08 (1.97%) 0.0 (0.0%) 0.0 (0.0%) -0.07 (-1.64%) --- 0.08 (1.97%) 0.0 (0.0%) 0.0 (0.0%)

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
0.02
Diluted EPS:
0.02
Basic P/E:
208.525
Diluted P/E:
208.525
RSI(14) 1m:
46.33
VWAP:
4.17
RVol:

Events

Period Kind Movement Occurred At

Related News